UnknownNot Applicable

International Low Anterior Resection Score Evaluation

Lithuania400 participantsStarted 2019-09-01

Plain-language summary

* Aim: The aim of this study is to perform a prospective, international 4 months cohort study evaluating bowel function before curative rectal cancer surgery and one year after the surgery using the LARS score. * Primary outcome measure: LARS score before surgery and 1 year after the surgery. * Primary comparison: Between average LARS score before and after curative surgery and also comparing these with publish LARS score on normal population.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients undergoing rectal cancer surgery on curative intent. * Elective surgery patients. * Laparoscopic, laparoscopic-converted, robotic, TaTME (transanal total mesorectal excision) and open cases will be included. * Patients aged 18 years and over should be included. Exclusion Criteria: * Patients undergoing a procedure purely for diagnosis or staging should be excluded. * Patients with palliative treatment. * Patients with recurrence should be excluded. * Patients with dementia * Patients who do not complete their treatment within 12 months of primary surgery e.g. including reversal of stoma, chemotherapy etc

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

LARS score change comparing before surgery and 1 year after the surgery.

Timeframe: 12 months

Trial details

NCT IDNCT04040842

SponsorNational Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

Contact for this trial

Audrius Dulskas, MD, PhD

867520094 audrius.dulskas@gmail.com

View on ClinicalTrials.gov More Low Anterior Resection Syndrome trials